Resignations are nothing out of the ordinary, but resignations of two senior level vaccine regulators at The FDA, right after Pfizer’s vaccine gained FDA approval?

Perhaps they left because they have ethical problems with the push for mass vaccination and refuse to be a part of what is clearly an obvious push by drug companies to generate profit.

Indeed, reports are indicating that they had problems with the current administration’s booster policies and pushes for the public to get booster vaccines without adequate research.

Join Our Telegram channel here: https://t.me/dailyusa24

Take a look through these reports, and let us know what you think:

The Epoch Times had more details:

According to a memo that was sent by Peter Marks, the head of FDA’s Center for Biologics Evaluation and Research (CBER) that oversees OVRR, and obtained by The Epoch Times, Gruber is leaving on Oct. 31. Krause is leaving sometime in November, the memo said.

Marks said in the memo that he would serve as the OVRR’s acting director while the FDA carries out a search for who should lead the division.

A LinkedIn profile for Gruber shows she worked for the FDA for 32 years and served as the OVRR’s director for about a decade. Krause, meanwhile, has worked for the FDA for about 11 years, according to his profile.

CNBC noted the two regulator’s frustration with The Biden Administration’s overreach on booster shots:

Endpoints News, a biotech industry publication, reported that the officials are leaving because they’re frustrated that the Centers for Disease Control and Prevention and its advisory committee are involved in decisions they think should be up to the FDA.

The final straw was when the White House got ahead of the agency on booster shots, according to Endpoints News, citing a former senior FDA leader.